Many children and adults have begun using this oral medication to treat neutropenia either as an alternative to G-CSF injections or in conjunction. Below are useful papers and videos. Please discuss with your medical team to see if this treatment is a good option for you or your loved one. Below are some helpful resources, but please consult with your medical team before trying anything.
Here is the most recent published paper reporting data on 112 patients using Empa: Click to Learn More
Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin
treatment. Click to Read More
Original Published scientific paper: Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Click to Learn More